Jingtian & Gongcheng is recommended for handling acquisitions and equity takeovers in the PRC healthcare and life sciences market, regularly assisting Chinese companies in this capacity. The firm is also well-recommended for overseeing collaborations in this space, including between research and development companies and major hospitals. The team, which is noted for its ability to ‘understand the needs of customers and provide very practical and operable legal opinions’, is jointly led by the corporate matters and licensing focussed Hanshuo Zhou and IPOs expert Yuanpeng Lang.
Testimonials
Collated independently by Legal 500 research team.
‘The life science and health care team of Jingtian & Gongcheng is excellent and strong. It has brilliant capabilities in serving listed companies, technology-based enterprises and innovative enterprises.’
‘I recommend Attorney Zhou and his team as an excellent group of lawyers in the field of healthcare.'
Key clients
- Thermo Fisher Scientific
- BGI and MGI
Work highlights
- Represented China General Technology (Group) Holding Co Ltd (“Genertec��) in its acquisition of Baoshihua Medical Group from 7 institutional investors including China National Petroleum Corporation.
- Assisted Conba with transferring 49.84% equity of Jiangxi Zhen Shi Ming Pharmaceutical (“ZSM”) to a group of both domestic and foreign investors.